Clinical trial Recruiting at 1 site Observational

Cervical Spinal Cord Signal Abnormalities in Patients with Neck Pain

Official title: Prevalence of Cervical Spinal Cord Signal Abnormalities and Determinants of Treatment Selection in Patients With Cervical Radicular Pain: A Prospective Cohort Study

Run by Ankara City Hospital Bilkent · NCT07823426 · Data updated 2026-11-12

This observational study tests how common cervical spinal cord signal changes are in adults with cervical radicular pain treated at a tertiary pain clinic.

More Cervical Radiculopathy trials

Quick facts

Study typeObservational
SexAll
Enrollment400 (estimated)
SponsorAnkara City Hospital Bilkent
Academic / other
Locations1 site (Ankara, Ankara)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedFebruary 28, 2027
Study endsMarch 31, 2027
Registry record updatedOctober 21, 2026
Trial IDNCT07823426 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with cervical radicular pain presenting to the pain clinic and with a qualifying cervical MRI and neurological examination.

Probably not a fit

Patients without cervical spinal cord abnormalities on MRI or without neurological involvement may not experience direct benefits from screening results.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study enrolls up to 400 adults with cervical radicular pain at Ankara Bilkent City Hospital. Researchers will record neurological findings, Hoffmann sign results, and routine cervical MRI findings to determine how often spinal cord signal abnormalities occur, including myelomalacia. Secondary goals include understanding how clinical and imaging factors relate to treatment decisions and whether Hoffmann sign predicts spinal cord abnormalities or surgical referrals. No interventions beyond standard clinical care and imaging are performed. The study relies on data collected during routine visits and MRI assessments.

Why it matters

Potential benefit: If successful, the findings could improve understanding of how common spinal cord changes are in this population and inform future diagnostic and treatment planning.

How similar studies have gone: Previous work in similar settings has shown that MRI-detected spinal cord changes can be present in patients with radicular symptoms, though prevalence estimates vary by population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Presentation to the pain clinic with cervical radicular pain
* Clinical symptoms and/or examination findings consistent with cervical nerve root involvement
* Availability of a cervical magnetic resonance imaging (MRI) examination suitable for evaluation
* Completion of standardized neurological examination at the initial visit
* Ability and willingness to provide written informed consent

Exclusion Criteria:

* Previous cervical spine surgery
* Acute cervical spine trauma
* Known cervical spinal malignancy
* Active spinal infection
* Known inflammatory, demyelinating, or other non-degenerative spinal cord disease
* Severe cognitive impairment or communication difficulty preventing reliable clinical assessment
* Inadequate or non-diagnostic cervical MRI quality
* Refusal to participate

Where it's running

  • Ankara Bilkent City Hospital
    Ankara, Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.